HCP Live

AAO 2019 Retina Street Team: Allen C. Ho, MD

Oct 13, 2019

AAO 2019 Retina Street Team

Allen C. Ho, MD, discusses precision subretinal delivery for gene and cell therapy along with Ben Ko, engineering manager, Kaleidoscope Innovation, at the 2019 meeting of the American Academy of Ophthalmology in San Francisco, CA.

Related Videos

Related Content

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

Alzheimer’s disease changes may be reflected in the eyes first

March 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

March 14th 2023

Managing a changing landscape of IRD pediatric cases

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

Related Content

Alzheimer’s disease changes may be reflected in the eyes first

Alzheimer’s disease changes may be reflected in the eyes first

ROP: Treating and preventing blindness in preterm babies

ROP: Treating and preventing blindness in preterm babies

Alvin Liu

How deep learning may play a role in predicting retinitis pigmentosa visual impairment

Managing a changing landscape of IRD pediatric cases

Managing a changing landscape of IRD pediatric cases

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

Study examines long-term treatment outcomes of intravitreal bevacizumab in myopic macular neovascularization in high myopia

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.